Published in JAMA on January 08, 1988
Ambulatory Blood Pressure and Behavior | NCT00005170
White Coat Hypertension and Antihypertensive Treatment Effect - SCOR in Hypertension | NCT00005316
Use and interpretation of ambulatory blood pressure monitoring: recommendations of the British hypertension society. BMJ (2000) 3.37
Prevalence and predictors of white-coat response in patients with treated hypertension. CMAJ (1999) 2.26
Monitoring ambulatory blood pressure in general practice. BMJ (1992) 2.19
Doctors record higher blood pressures than nurses: systematic review and meta-analysis. Br J Gen Pract (2014) 1.91
The placebo effect: can we use it better? BMJ (1994) 1.76
An evidence-based approach to the clinical examination. J Gen Intern Med (1997) 1.60
Physical diagnosis versus modern technology. A review. West J Med (1990) 1.49
Ambulatory blood pressure measurement in general practice. Br J Gen Pract (1992) 1.36
Report of the Canadian Hypertension Society Consensus Conference: 2. Diagnosis of hypertension in adults. CMAJ (1993) 1.32
Masked hypertension and white-coat hypertension in chronic kidney disease: a meta-analysis. Clin J Am Soc Nephrol (2009) 1.26
Unmasking masked hypertension: prevalence, clinical implications, diagnosis, correlates and future directions. J Hum Hypertens (2014) 1.25
Principles and techniques of blood pressure measurement. Cardiol Clin (2010) 1.20
A novel approach to office blood pressure measurement: 30-minute office blood pressure vs daytime ambulatory blood pressure. Ann Fam Med (2011) 1.19
Modern approaches to blood pressure measurement. Occup Environ Med (2000) 1.19
Clinical correlates of ambulatory BP monitoring among patients with CKD. Clin J Am Soc Nephrol (2013) 1.03
Diagnosis and management of patients with white-coat and masked hypertension. Nat Rev Cardiol (2011) 1.03
Overdiagnosing hypertension. BMJ (1988) 1.01
Management of mild hypertension. Selecting an antihypertensive regimen. West J Med (1991) 0.98
Pressure for change: unresolved issues in blood pressure measurement. Br J Gen Pract (1999) 0.98
Role of Ambulatory and Home Blood Pressure Monitoring in Clinical Practice: A Narrative Review. Ann Intern Med (2015) 0.97
Ambulatory blood pressure and cardiovascular events in chronic kidney disease. Semin Nephrol (2007) 0.93
Monitoring ambulatory blood pressure in general practice. BMJ (1992) 0.92
Home blood pressure monitoring for mild hypertensives. Public Health Rep (1991) 0.90
Closer look at white-coat hypertension. World J Methodol (2014) 0.90
Withdrawing antihypertensive treatment. BMJ (1991) 0.89
The Role of Ambulatory Assessment in Psychological Science. Curr Dir Psychol Sci (2014) 0.89
Mathematical modeling the neuroregulation of blood pressure using a cognitive top-down approach. N Am J Med Sci (2010) 0.88
Noise perception, heart rate and blood pressure in relation to aircraft noise in the vicinity of the Frankfurt airport. Clin Res Cardiol (2007) 0.88
Ambulatory blood pressure monitoring in the management of hypertension. Heart (2003) 0.87
Age and the difference between awake ambulatory blood pressure and office blood pressure: a meta-analysis. Blood Press Monit (2011) 0.87
Ambulatory blood pressure monitoring in clinical practice: a review. Am J Med (2014) 0.87
Clinical efficacy and safety of olmesartan/hydrochlorothiazide combination therapy in patients with essential hypertension. Vasc Health Risk Manag (2008) 0.86
Ambulatory blood pressure monitoring in the diagnosis and management of hypertension. Diabetes Care (2013) 0.86
Comparing the effects of white coat hypertension and sustained hypertension on mortality in a UK primary care setting. Ann Fam Med (2008) 0.85
Clinic Blood Pressure Underestimates Ambulatory Blood Pressure in an Untreated Employer-Based US Population: Results From the Masked Hypertension Study. Circulation (2016) 0.85
I Brazilian position paper on prehypertension, white coat hypertension and masked hypertension: diagnosis and management. Arq Bras Cardiol (2014) 0.84
Knowledge regarding risk factors of hypertension among entry year students of a medical university. J Family Community Med (2011) 0.83
Toward a definition of masked hypertension and white-coat hypertension among hemodialysis patients. Clin J Am Soc Nephrol (2011) 0.83
Stressful life events and current psychological distress are associated with self-reported hypertension but not with true hypertension: results from a cross-sectional population-based study. BMC Public Health (2008) 0.81
The use of ambulatory blood pressure monitoring among Medicare beneficiaries in 2007-2010. J Am Soc Hypertens (2014) 0.81
Cost-effectiveness of secondary screening modalities for hypertension. Blood Press Monit (2013) 0.81
Factors associated with the accuracy of physicians' predictions of patient adherence. Patient Educ Couns (2011) 0.81
Effects of age on arterial stiffness and blood pressure variables in patients with newly diagnosed untreated hypertension. Korean Circ J (2015) 0.80
Activity restrictions and recovery after open chest surgery: understanding the patient's perspective. Proc (Bayl Univ Med Cent) (2008) 0.80
Endothelial damage in white coat hypertension: role of lectin-like oxidized low-density lipoprotein-1. J Hum Hypertens (2014) 0.80
Noninvasive 24 hour ambulatory blood pressure monitoring: current status. Postgrad Med J (1993) 0.79
Transforming health care delivery through consumer engagement, health data transparency, and patient-generated health information. Yearb Med Inform (2014) 0.79
Studies comparing ambulatory blood pressure and home blood pressure on cardiovascular disease and mortality outcomes: a systematic review. J Am Soc Hypertens (2015) 0.79
Prevalence of the use of antihypertensive medications in Greenland: a study of quality of care amongst patients treated with antihypertensive drugs. Int J Circumpolar Health (2012) 0.79
The Blood Pressure "Uncertainty Range" - a pragmatic approach to overcome current diagnostic uncertainties (II). Curr Control Trials Cardiovasc Med (2005) 0.78
Effect of short-term isometric handgrip training on blood pressure in middle-aged females. Cardiovasc J Afr (2010) 0.78
Diagnostic value and cost-benefit analysis of 24 hours ambulatory blood pressure monitoring in primary care in Portugal. BMC Cardiovasc Disord (2013) 0.78
Mobile personal health system for ambulatory blood pressure monitoring. Comput Math Methods Med (2013) 0.78
Clinical value of ambulatory blood pressure: Is it time to recommend for all patients with hypertension? Clin Exp Nephrol (2015) 0.78
Community-based home-care program for the management of pre-eclampsia: an alternative. CMAJ (1993) 0.78
Hypertension: a cross-sectional study of the role of multimorbidity in blood pressure control. BMC Fam Pract (2015) 0.78
Hypertension. Postgrad Med J (1991) 0.78
Differential expression of hypertension-associated microRNAs in the plasma of patients with white coat hypertension. Medicine (Baltimore) (2015) 0.78
The Utility of Ambulatory Blood Pressure Monitoring for Diagnosing White Coat Hypertension in Older Adults. Curr Hypertens Rep (2015) 0.78
Isolated office hypertension: association with target organ damage and cardiovascular risk indices. J Natl Med Assoc (2006) 0.77
White coat hypertension: relevance to clinical and emergency medical services personnel. MedGenMed (2007) 0.77
Ambulatory blood pressure monitoring for hypertension in general practice. J R Soc Med (1998) 0.77
Parity as a factor affecting the white-coat effect in pregnant women: the BOSHI study. Hypertens Res (2015) 0.77
Exploiting placebo effects for therapeutic benefit. Health Care Anal (2005) 0.76
Machine learning approach to extract diagnostic and prognostic thresholds: application in prognosis of cardiovascular mortality. Comput Math Methods Med (2012) 0.76
Discrepancies in office and ambulatory blood pressure in adolescents: help or hindrance? Pediatr Nephrol (2007) 0.75
Evidence from single nucleotide polymorphism analyses of ADVANCE study demonstrates EFNB3 as a hypertension risk gene. Sci Rep (2017) 0.75
Clinic blood pressure measurements and blood pressure load in the diagnosis of hypertension. Postgrad Med J (1993) 0.75
Procalcitonin and Pentraxin-3: Current biomarkers in inflammation in white coat hypertension. J Hum Hypertens (2015) 0.75
In Sync: The Effect of Physiology Feedback on the Match between Heart Rate and Self-Reported Stress. Biomed Res Int (2015) 0.75
Long-term therapy of hypertension. Korean J Intern Med (1995) 0.75
The diagnosis and treatment of hypertension: does ambulatory pressure monitoring have a role? CMAJ (1989) 0.75
Ambulatory Blood Pressure Monitoring: A Complementary Strategy for Hypertension Diagnosis and Management in Low-Income and Middle-Income Countries. Cardiol Clin (2017) 0.75
Decoding white coat hypertension. World J Clin Cases (2017) 0.75
Role of Ambulatory Blood Pressure Measurement in Diagnosis and Control of Hypertension. Med J Armed Forces India (2011) 0.75
Discrepancies in Clinic and Ambulatory Blood Pressure in Korean Chronic Kidney Disease Patients. J Korean Med Sci (2017) 0.75
Novel Approaches to Investigate One-Carbon Metabolism and Related B-Vitamins in Blood Pressure. Nutrients (2016) 0.75
A stress-related explanation to the increased blood pressure and its course following ischemic stroke. Vasc Health Risk Manag (2016) 0.75
Effects of olmesartan-based treatment on masked, white-coat, poorly controlled, and well-controlled hypertension: HONEST study. J Clin Hypertens (Greenwich) (2014) 0.75
[Hypertension. A new way to approach an old problem]. Can Fam Physician (1996) 0.75
Comparison of quinapril and atenolol as single drugs or in combination with hydrochlorothiazide in moderate to severe hypertensives, using automated ambulatory monitoring. Br J Clin Pharmacol (1993) 0.75
Does "white coat hypertension" increase the risk for any adverse outcome from hypertension? West J Med (2000) 0.75
A Comparison of Casual In-Clinic Blood Pressure Measurements to Standardized Guideline-Concordant Measurements in Severely Obese Individuals. Int J Hypertens (2015) 0.75
White coat hypertension and related phenomena. A clinical approach. Drugs (1993) 0.75
Pre-anesthesia systolic blood pressure increases with age regardless of sex. J Anesth (2012) 0.75
Reflections on the U.S. Preventive Services Task Force recommendations for screening for hypertension and hypercholesterolemia. J Gen Intern Med (1990) 0.75
Relation of left ventricular mass and geometry to morbidity and mortality in uncomplicated essential hypertension. Ann Intern Med (1991) 6.08
Essential hypertension: renin and aldosterone, heart attack and stroke. N Engl J Med (1972) 4.80
Patterns of left ventricular hypertrophy and geometric remodeling in essential hypertension. J Am Coll Cardiol (1992) 4.65
Low urinary sodium is associated with greater risk of myocardial infarction among treated hypertensive men. Hypertension (1995) 4.35
Association of the renin-sodium profile with the risk of myocardial infarction in patients with hypertension. N Engl J Med (1991) 3.86
Propranolol inhibition of renin secretion. A specific approach to diagnosis and treatment of renin-dependent hypertensive diseases. N Engl J Med (1972) 3.73
Modern strategies to prevent coronary sequelae and stroke in hypertensive patients differ from the JNC V Consensus Guidelines. Am J Hypertens (1994) 2.91
Effect of growth on variability of left ventricular mass: assessment of allometric signals in adults and children and their capacity to predict cardiovascular risk. J Am Coll Cardiol (1995) 2.74
Relation of sleepiness to respiratory disturbance index: the Sleep Heart Health Study. Am J Respir Crit Care Med (1999) 2.72
Standardization of M-mode echocardiographic left ventricular anatomic measurements. J Am Coll Cardiol (1984) 2.64
Diagnosis and treatment of primary hyperaldosteronism. Ann Intern Med (1994) 2.62
Renin is not synthesized by cardiac and extrarenal vascular tissues. A review of experimental evidence. Circulation (1994) 2.50
Value of echocardiographic measurement of left ventricular mass in predicting cardiovascular morbid events in hypertensive men. Ann Intern Med (1986) 2.36
Clinical experience with blockade of the renin-angiotensin-aldosterone system by an oral converting-enzyme inhibitor (SQ 14,225, captopril) in hypertensive patients. Prog Cardiovasc Dis (1979) 2.29
Hyperuricemia in primary and renal hypertension. N Engl J Med (1966) 2.22
Renin, angiotensin and aldosterone system in pathogenesis and management of hypertensive vascular disease. Am J Med (1972) 2.10
Possible nosocomial transmission of HIV. Lancet (1994) 2.05
Calcium-regulating hormones in essential hypertension. Relation to plasma renin activity and sodium metabolism. Ann Intern Med (1986) 2.04
Usefulness and limitations of saralasin, a partial competitive agonist of angioten II, for evaluating the renin and sodium factors in hypertensive patients. Am J Med (1976) 1.98
The renin system: Variations in man measured by radioimmunoassay or bioassay. Kidney Int (1972) 1.87
Atrial natriuretic factor in normal subjects and heart failure patients. Plasma levels and renal, hormonal, and hemodynamic responses to peptide infusion. J Clin Invest (1986) 1.84
Reversal of vascular and renal crises of scleroderma by oral angiotensin-converting-enzyme blockade. N Engl J Med (1979) 1.83
Vasoconstriction-volume analysis for understanding and treating hypertension: the use of renin and aldosterone profiles. Am J Med (1973) 1.82
An angiotensin converting-enzyme inhibitor to identify and treat vasoconstrictor and volume factors in hypertensive patients. N Engl J Med (1974) 1.82
Amiloride. A potassium-sparing natriuretic agent. Circulation (1968) 1.80
Angiotensin-II blockade in man by sar1-ala8-angiotensin II for understanding and treatment of high blood-pressure. Lancet (1973) 1.78
Effects of auriculin (atrial natriuretic factor) on blood pressure, renal function, and the renin-aldosterone system in dogs. Am J Med (1984) 1.76
Atrial natriuretic hormone, the renin-aldosterone axis, and blood pressure-electrolyte homeostasis. N Engl J Med (1985) 1.75
Direct relationship between blood pressure and blood viscosity in normal and hypertensive subjects. Role of fibrinogen and concentration. Am J Med (1981) 1.75
Relation of left ventricular hemodynamic load and contractile performance to left ventricular mass in hypertension. Circulation (1990) 1.72
Elevation of ambulatory systolic blood pressure in hypertensive smokers. A case-control study. JAMA (1991) 1.70
Blood pressure during normal daily activities, sleep, and exercise. Comparison of values in normal and hypertensive subjects. JAMA (1982) 1.68
Assessment of left ventricular function by the midwall fractional shortening/end-systolic stress relation in human hypertension. J Am Coll Cardiol (1994) 1.67
Longitudinal study of the renin-angiotensin-aldosterone system in hypertensive pregnant women: deviations related to the development of superimposed preeclampsia. Am J Obstet Gynecol (1990) 1.65
Possible role of renin in hypertension as suggested by renin-sodium profiling and inhibition of converting enzyme. N Engl J Med (1977) 1.64
Relation of obesity and gender to left ventricular hypertrophy in normotensive and hypertensive adults. Hypertension (1994) 1.63
A longitudinal study of urinary creatinine and creatinine clearance in normal subjects. Race, sex, and age differences. Am J Hypertens (1988) 1.60
Purification, sequencing and synthesis of natriuretic and vasoactive rat atrial peptide. Nature (1984) 1.60
Left ventricular hypertrophy in patients with hypertension: importance of blood pressure response to regularly recurring stress. Circulation (1983) 1.60
Possible role of increased blood viscosity in the hemodynamics of systemic hypertension. Am J Cardiol (2000) 1.58
Atrial natriuretic factor: structure and functional properties. Kidney Int (1985) 1.56
The prevalence and correlates of echocardiographic left ventricular hypertrophy among employed patients with uncomplicated hypertension. J Am Coll Cardiol (1986) 1.56
Cyclic psychosis associated with the menstrual cycle. Br J Psychiatry (1993) 1.55
Salt and hypertension. Lancet (1984) 1.52
Relation between potassium balance and aldosterone secretion in normal subjects and in patients with hypertensive or renal tubular disease. J Clin Invest (1966) 1.51
Impedance cardiography for determination of stroke index. J Appl Physiol (1976) 1.50
Physiologic and clincical observations on furosemide and ethacrynic acid. Ann N Y Acad Sci (1966) 1.50
Oral contraceptives. Renin, aldosterone, and high blood pressure. JAMA (1967) 1.49
Divergent blood pressure responses during short-term sodium restriction in hypertension. Clin Pharmacol Ther (1980) 1.49
Natriuretic activity in plasma and urine of salt-loaded man and sheep. J Clin Invest (1969) 1.48
Hypertension and a tumor of the glomus jugulare region. Evidence for epinephrine biosynthesis. Am J Hypertens (1993) 1.47
Disparate patterns of aldosterone response during diuretic treatment of hypertension. Ann Intern Med (1977) 1.45
Cardiac arrest postoperatively in a patient infected with ascaris, the roundworm. Chest (1989) 1.43
Role of the kidney in congestive heart failure. Relationship of cardiac index to kidney function. Drugs (1990) 1.43
Echocardiographic assessment of cardiac anatomy and function in hypertensive subjects. Circulation (1979) 1.42
What is the role of ambulatory blood pressure monitoring in the management of hypertensive patients? Hypertension (1985) 1.42
Hypertension: steps forward and steps backward. The Joint National Committee fifth report. Arch Intern Med (1993) 1.42
The influence of potassium administration and of potassium deprivation on plasma renin in normal and hypertensive subjects. J Clin Invest (1970) 1.42
Plasma renin activity: a risk factor for myocardial infarction in hypertensive patients. Am J Hypertens (1997) 1.41
Recurrent pulmonary oedema in hypertension due to bilateral renal artery stenosis: treatment by angioplasty or surgical revascularisation. Lancet (1988) 1.40
Renin and prorenin: advances and declines in methodology. Clin Chem (1996) 1.40
Furosemide. A clinical evaluation of its diuretic action. Circulation (1966) 1.40
Interruption of the renin-angiotensin system in hypertensive patients by captopril induces sustained reduction in aldosterone secretion, potassium retention and natruiresis. Hypertension (1980) 1.39
Relation of blood viscosity to demographic and physiologic variables and to cardiovascular risk factors in apparently normal adults. Circulation (1990) 1.39
CORRELATION OF STRUCTURE AND FUNCTION IN THE HANDLING OF GLUCOSE BY THE NEPHRONS OF THE CANINE KIDNEY. J Clin Invest (1961) 1.37
Midwall left ventricular mechanics. An independent predictor of cardiovascular risk in arterial hypertension. Circulation (1996) 1.37
Prorenin and other large molecular weight forms of renin. Endocr Rev (1980) 1.33
THE NATURE OF THE ACTION OF INTRAVENOUS ALDOSTERONE: EVIDENCE FOR A ROLE OF THE HORMONE IN URINARY DILUTION. J Clin Invest (1961) 1.33
Estimating renin participation in hypertension: superiority of converting enzyme inhibitor over saralasin. Am J Med (1976) 1.33
Percutaneous transluminal renal angioplasty in renovascular hypertension due to atheroma or fibromuscular dysplasia. N Engl J Med (1983) 1.30
Suppression of the renin-angiotensin system by intravenous digoxin in chronic congestive heart failure. Am J Med (1983) 1.27
Malignant hypertension resulting from deoxycorticosterone acetate and salt excess: role of renin and sodium in vascular changes. Circ Res (1975) 1.27
Elevated blood viscosity in patients with borderline essential hypertension. Hypertension (1983) 1.24
Human urinary kallikrein converts inactive to active renin and is a possible physiological activator of renin. Nature (1978) 1.23
Secondary aldosteronism and reduced plasma renin in hypertensive disease. Trans Assoc Am Physicians (1967) 1.22
The reproducibility of average ambulatory, home, and clinic pressures. Hypertension (1988) 1.21
Angiotensin II vascular receptors: their avidity in relationship to sodium balance, the autonomic nervous system, and hypertension. J Clin Invest (1972) 1.21
Effect of corticotropin on aldosterone excretion and plasma renin in normal subjects, in essential hypertension and in primary aldosteronism. J Clin Endocrinol Metab (1968) 1.20
Prorenin in high concentrations in human ovarian follicular fluid. Science (1986) 1.20
Attenuated salivary cortisol secretion under cue exposure is associated with early relapse. Alcohol Alcohol (2004) 1.20
What is the value of home blood pressure measurement in patients with mild hypertension? Hypertension (1984) 1.19
Hemodynamic function at rest, during acute stress, and in the field: predictors of cardiac structure and function 2 years later in youth. Hypertension (1999) 1.18
Regulation of glomerular filtration rate in chronic congestive heart failure patients. Kidney Int (1988) 1.18
Hypertension of renal origin: evidence for two different mechanisms. Science (1971) 1.16
Prior receptor occupancy as a determinant of the pressor activity of infused angiotensin II in the rat. Circ Res (1975) 1.16
Potassium balance and the control of renin secretion. J Clin Invest (1970) 1.15
Nephrotic syndrome: vasoconstriction and hypervolemic types indicated by renin-sodium profiling. Ann Intern Med (1979) 1.15
Variable response to oral angiotensin-converting-enzyme blockade in hypertensive scleroderma patients. Arthritis Rheum (1982) 1.14
The meaning of aldosteronism in hypertensive disease. Circ Res (1967) 1.14
Physiological and pathological variations of plasma angiotensin II in man. Correlation with renin activity and sodium balance. Circ Res (1969) 1.14
Antihypertensive action of propranolol. Specific antirenin responses in high and normal renin forms of essential, renal, renovascular and malignant hypertension. Am J Cardiol (1973) 1.13
High blood pressure and oral contraceptives. Changes in plasma renin and renin substrate and in aldosterone excretion. Am J Obstet Gynecol (1968) 1.13